A dataset containing predictions for chemo-censitivity and pathological response from Hatzis (2011)
validate: Validation status
drfs: Censoring status; 0=censored, 1=event.
drfs.time: Time to event or censoring
er.status: ER status, P=positive, N=negative
chemo.pred: Prediction for chemo sensitivity from the ACES predictor, sensitive or insensitive
pre.N: Prediction of nodal status
pCR.RD: pathological complete response (pCR) or residual disease (RD)
pre.grade: prediction of tumor grade
pre.T: T stage prediction
dlda30: DLDA30 prediction for the pathological response.
 Hatzis, C., Pusztai, L., Valero, V., Booser, D. J., Esserman, L., Lluch, A., et al. (2011). A genomic predictor of response and survival following taxane-anthracycline chemotherapy for invasive breast cancer. The Journal of the American Medical Association 305, 1873–1881.
Add the following code to your website.
For more information on customizing the embed code, read Embedding Snippets.